SCHEMBL26257500

SCHEMBL26257500

CC(C)Oc1cccc(C(C)(C)OCc2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
CETP P11597 1/20 0.39
MAOB P27338 2/20 0.39
BCHE P06276 1/20 0.39
PKM P14618 1/20 0.38
SLC16A3 O15427 2/20 0.38
SLC16A1 P53985 2/20 0.38
MCTS1 Q9ULC4 2/20 0.38
CACNA1B Q00975 1/20 0.38
PTPN5 P54829 1/20 0.38
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
MCL1 Q07820 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA5 P31644 1/20 0.37
GABRA3 P34903 1/20 0.37
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9956202 0.83 MAPK1 (0.43) MAOB
SCHEMBL9176021 0.78 MAPK1 (0.54)
SCHEMBL19223059 0.75 TSHR (0.52) CETPMAOBBCHERXRARXRB
SCHEMBL14444136 0.75 MAOB (0.67) MAOBBCHE
SCHEMBL7807816 0.74 ACHE (0.47) PTPN5RXRARXRBGABRA1GABRG2
SCHEMBL14325360 0.72 NPC1 (0.44) PPARGPPARAPTPN5RXRARXRB
SCHEMBL19223053 0.72 MAOB (0.53) MAOBBCHEMCL1
SCHEMBL21536114 0.72 TAAR1 (0.45) CETPMAOBBCHERXRARXRB
SCHEMBL12614560 0.72 RXRA (0.41) PPARGPPARAPTPN5RXRARXRB
SCHEMBL1416801 0.71 RXRA (0.42) PPARGPPARACETPPTPN5RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295111-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF GILEAD SCIENCES, INC. 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295111-A1 IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF IKZF2, IKZF1, IKZF3 PPARG 3198/4885PPARA 3563/4885CETP 1303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.